| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_13a89b946cff4cbe6caaf9d1d3c0d7b1 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-485
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-7023
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M31-002 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61M31-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-485
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-70
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61M35-00 |
| filingDate |
1997-03-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0adbf1985add2347b34c37167a59984d |
| publicationDate |
1999-03-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
EP-0900076-A1 |
| titleOfInvention |
Transdermal device |
| abstract |
The invention provides a transdermal device suitable for continuous administration of an opiate/opioid analgesic for a period of about 24 to about 144 hours via an area of skin for which the epidermis has been removed. The device has incorporated therein from 11 to 3000 mg of morphine or a salt thereof or from 11/P to 3000/P mg of another opiate/opioid analgesic for which P is the level of analgesic effect of said other opiate/opioid analgesic relative to morphine. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9326979-B2 |
| priorityDate |
1996-03-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |